beta-lapachone has been researched along with Metabolic Syndrome in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacological activation of NADH oxidation by NQO1 resolves obesity and related phenotypes in mice, opening the possibility that it may provide the basis for a new therapy for the treatment of metabolic syndrome." | 7.75 | Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. ( Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK, 2009) |
| "Pharmacological activation of NADH oxidation by NQO1 resolves obesity and related phenotypes in mice, opening the possibility that it may provide the basis for a new therapy for the treatment of metabolic syndrome." | 3.75 | Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. ( Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, JH | 1 |
| Kim, DW | 1 |
| Jo, EJ | 1 |
| Kim, YK | 1 |
| Jo, YS | 1 |
| Park, JH | 1 |
| Yoo, SK | 1 |
| Park, MK | 1 |
| Kwak, TH | 1 |
| Kho, YL | 1 |
| Han, J | 1 |
| Choi, HS | 1 |
| Lee, SH | 1 |
| Kim, JM | 1 |
| Lee, I | 1 |
| Kyung, T | 1 |
| Jang, C | 1 |
| Chung, J | 1 |
| Kweon, GR | 1 |
| Shong, M | 1 |
1 other study available for beta-lapachone and Metabolic Syndrome
| Article | Year |
|---|---|
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
Topics: Adenylate Kinase; Animals; Disease Models, Animal; Energy Metabolism; Metabolic Syndrome; Mice; Mice | 2009 |